STERIS ROE 2010-2022 | STE

Current and historical return on equity (ROE) values for STERIS (STE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
STERIS ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2022-09-30 $-0.01B $5.81B -0.13%
2022-06-30 $0.38B $6.42B 5.77%
2022-03-31 $0.24B $6.55B 3.71%
2021-12-31 $0.28B $6.62B 4.72%
2021-09-30 $0.25B $6.55B 4.78%
2021-06-30 $0.29B $6.59B 6.35%
2021-03-31 $0.40B $3.89B 10.67%
2020-12-31 $0.43B $3.88B 12.02%
2020-09-30 $0.42B $3.66B 12.14%
2020-06-30 $0.41B $3.49B 12.20%
2020-03-31 $0.41B $3.42B 12.27%
2019-12-31 $0.39B $3.40B 12.03%
2019-09-30 $0.34B $3.24B 10.52%
2019-06-30 $0.32B $3.25B 10.04%
2019-03-31 $0.30B $3.19B 9.68%
2018-12-31 $0.27B $3.11B 8.57%
2018-09-30 $0.32B $3.13B 10.06%
2018-06-30 $0.30B $3.10B 9.72%
2018-03-31 $0.29B $3.22B 9.45%
2017-12-31 $0.24B $3.12B 8.16%
2017-09-30 $0.14B $3.04B 4.95%
2017-06-30 $0.12B $2.94B 4.13%
2017-03-31 $0.11B $2.81B 3.75%
2016-12-31 $0.14B $2.77B 4.75%
2016-09-30 $0.17B $3.01B 5.49%
2016-06-30 $0.14B $3.05B 5.31%
2016-03-31 $0.11B $3.04B 5.40%
2015-12-31 $0.09B $2.99B 6.01%
2015-09-30 $0.11B $1.09B 10.32%
2015-06-30 $0.13B $1.10B 12.41%
2015-03-31 $0.14B $1.07B 12.61%
2014-12-31 $0.13B $1.08B 12.51%
2014-09-30 $0.12B $1.07B 11.85%
2014-06-30 $0.12B $1.07B 11.98%
2014-03-31 $0.13B $1.04B 12.96%
2013-12-31 $0.13B $1.01B 13.47%
2013-09-30 $0.15B $0.99B 15.77%
2013-06-30 $0.16B $0.97B 17.31%
2013-03-31 $0.16B $0.95B 17.76%
2012-12-31 $0.16B $0.92B 18.74%
2012-09-30 $0.15B $0.88B 17.84%
2012-06-30 $0.14B $0.83B 17.18%
2012-03-31 $0.14B $0.82B 17.15%
2011-12-31 $0.13B $0.78B 16.70%
2011-09-30 $0.12B $0.78B 15.32%
2011-06-30 $0.13B $0.82B 16.33%
2011-03-31 $0.05B $0.79B 7.01%
2010-12-31 $0.04B $0.75B 5.87%
2010-09-30 $0.06B $0.73B 8.51%
2010-06-30 $0.06B $0.70B 7.77%
2010-03-31 $0.13B $0.75B 16.91%
2009-12-31 $0.13B $0.73B 16.84%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $19.157B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
Teleflex (TFX) United States $11.378B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00